In this case study, IMA Active and Zambon discuss how the Cyclops tumble bin blender assisted the formulation and blending from laboratory scale while following recommended guidelines.
Jamie Clayton, operations director at Freeman Technology, explains how comprehensive, process relevant characterisation of wet granules can lead to control of tablet CQAs and assist design space definition in the manufacture of an OTC medicine.
Soft gels have seen huge growth in the pharmaceutical industry in recent years thanks to versatility and convenience, here, Pierre-Albert Thomas, Rousselot, discusses this trend and how soft gels can benefit the sector
Speed to market is a significant concern in tablet manufacturing, however, moving too quickly may cause problems. Here, Dr Charles Kettler and Robert Sedlock reveal anticipatory experiments to help make the transition from R&D to full scale smooth.
Dr Charles Kettler, director Natoli Scientific analyses common sticking and picking issues in tablet manufacturing and how a little homework can go a long way in avoiding potential issues before they arise.
Dr Thomas Hein, senior vice president, commercial and regulatory affairs at Hermes Pharma examines the benefits of multiple oral solid dosage forms and their impact on certain APIs.
Sophisticated solid dose formulations for fixed dose combinations – Jean-François Hilaire, Recipharm, explains how CDMOs can help optimise time-to-market
